THROMBOLYTIC AND ANTICOAGULANT THERAPY FOR PULMONARY EMBOLISM WITH HIGH AND INTERMENDIATE RISK OF EARLY DEATH. PART 1. MORTALITY ANDCOMPLICATIONS
Background The advantages of thrombolytic therapy over anticoagulant therapy in the treatment of acute pulmonary embolism are uncertain. Aim of study To compare primary outcomes and incidence of complications in patients with PE of high and intermediate risk in the course of TLT or ACT and to assess...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Sklifosovsky Research Institute for Emergency Medicine, Public Healthcare Institution of Moscow Healthcare Department
2018-04-01
|
Series: | Neotložnaâ Medicinskaâ Pomoŝʹ |
Subjects: | |
Online Access: | https://www.jnmp.ru/jour/article/view/433 |